# Entecavir for Decompensated HBV Cirrhosis

> **NCT03345498** · — · COMPLETED · sponsor: **Sanjay Gandhi Postgraduate Institute of Medical Sciences** · enrollment: 32 (actual)

## Conditions studied

- Hepatitis B
- Liver Cirrhosis

## Interventions

- **DRUG:** Entecavir

## Key facts

- **NCT ID:** NCT03345498
- **Lead sponsor:** Sanjay Gandhi Postgraduate Institute of Medical Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-12-31
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2019-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03345498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03345498, "Entecavir for Decompensated HBV Cirrhosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03345498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*